Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof
US-2024101580-A1 · Mar 28, 2024 · US
US10072028B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10072028-B2 |
| Application number | US-201415034102-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 3, 2014 |
| Priority date | Nov 3, 2013 |
| Publication date | Sep 11, 2018 |
| Grant date | Sep 11, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided are methods for site- and stereo-retentive cross-couplings with unactivated secondary boronic acids, which methods are particularly useful in building block-based approach for small molecule synthesis. Also provided is a method of forming an air-stable chiral secondary boronic acid.
Opening claim text (preview).
We claim: 1. A method of forming a chiral non-racemic secondary boronic acid, comprising: combining a chiral compound of formula (I) wherein, independently for each occurrence, R 1 and R 2 are selected from the group consisting of substituted C 1 -C 6 alkyl and unsubstituted C 1 -C 6 alkyl; a chiral iminodiacetic acid, wherein the chiral iminodiacetic acid is not a racemic mixture; pyridinium p-toluenesulfonate (PPTS); and a polar aprotic solvent, thereby forming a mixture of chiral boronates; resolving the mixture of chiral boronates into individual diastereomers; and hydrolyzing an individual diastereomer, thereby forming the chiral non-racemic secondary boronic acid. 2. The method of claim 1 , wherein the hydrolyzing is with aqueous hydroxide. 3. The method of claim 1 , wherein the chiral iminodiacetic acid has an enantiomeric excess of at least 80 percent. 4. The method of claim 1 , wherein the chiral iminodiacetic acid is benzylcyclopentyl iminodiacetic acid (BIDA). 5. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 80 percent. 6. The method of claim 1 , wherein the resolving is by crystallization. 7. The method of claim 1 , wherein the resolving is by chromatography. 8. The method of claim 1 , wherein the hydrolyzing is with aqueous NaOH. 9. The method of claim 1 , wherein the chiral iminodiacetic acid has an enantiomeric excess of at least 90 percent. 10. The method of claim 1 , wherein the chiral iminodiacetic acid has an enantiomeric excess of at least 95 percent. 11. The method of claim 1 , wherein the polar aprotic solvent is CH 3 CN. 12. The method of claim 1 , wherein the compound of formula (I) is a racemic mixture. 13. The method of claim 1 , wherein the compound of formula (I) is not a racemic mixture. 14. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 90 percent. 15. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 95 percent. 16. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 80 percent; and the chiral iminodiacetic acid has an enantiomeric excess of at least 80 percent. 17. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 90 percent; and the chiral iminodiacetic acid has an enantiomeric excess of at least 90 percent. 18. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 95 percent; and the chiral iminodiacetic acid has an enantiomeric excess of at least 95 percent. 19. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 80 percent; the chiral iminodiacetic acid has an enantiomeric excess of at least 80 percent; and the compound of formula (I) is a racemic mixture. 20. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 90 percent; the chiral iminodiacetic acid has an enantiomeric excess of at least 90 percent; and the compound of formula (I) is a racemic mixture. 21. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 95 percent; the chiral iminodiacetic acid has an enantiomeric excess of at least 95 percent; and the compound of formula (I) is a racemic mixture. 22. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 95 percent; the chiral iminodiacetic acid has an enantiomeric excess of at least 95 percent; and the chiral iminodiacetic acid is benzylcyclopentyl iminodiacetic acid (BIDA). 23. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 95 percent; the chiral iminodiacetic acid has an enantiomeric excess of at least 95 percent; the chiral iminodiacetic acid is benzylcyclopentyl iminodiacetic acid (BIDA); and the compound of formula (I) is a racemic mixture. 24. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 95 percent; the chiral iminodiacetic acid has an enantiomeric excess of at least 95 percent; the chiral iminodiacetic acid is benzylcyclopentyl iminodiacetic acid (BIDA); the compound of formula (I) is a racemic mixture; and the hydrolyzing is with aqueous hydroxide. 25. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 95 percent; the chiral iminodiacetic acid has an enantiomeric excess of at least 95 percent; the chiral iminodiacetic acid is benzylcyclopentyl iminodiacetic acid (BIDA); the compound of formula (I) is a racemic mixture; and the hydrolyzing is with aqueous NaOH. 26. The method of claim 1 , wherein the chiral non-racemic secondary boronic acid has an enantiomeric excess of at least 95 percent; the chiral iminodiacetic acid has an enantiomeric excess of at least 95 percent; the chiral iminodiacetic acid is benzylcyclopentyl iminodiacetic acid (BIDA); the compound of formula (I) is a racemic mixture; the hydrolyzing is with aqueous NaOH; and the polar aprotic solvent is CH 3 CN.
Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring · CPC title
Substitution · CPC title
by increase in the number of carbon atoms · CPC title
containing two rings · CPC title
Boronic and borinic acid compounds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.